摘要
AIMTostudytheeffectofketoconazole(KTZ),aselectiveinhibitorofCYP3A,oninvivoandinvitrometabolicactivityofhepaticCYP3Ainratwithmidazolam(MDZ)asprobe,whichwasassessedbypharmacokineticparametersofMDZ.,andtoestablishasuitablemarkerorindicatorforestimatingdrugmetabolizingactivityofhepaticCYP3A.METHODS1.Invivostudy:SeveralloadingdosesofKTZpreparedinamixtureofPEG400andpropyleneglycol(9:1)wereadministratedthroughratsublingualveinfollowedbyconstantinfusionatdifferentratesthroughtailveinwithanattempttoachievecorrespondingsteady-stateplasmaconcentrationsinordertoattaincontinuousinhibitiononCYP3A.
出版日期
2005年02月12日（中国期刊网平台首次上网日期，不代表论文的发表时间）
